Polycystic ovarian syndrome (PCOS) is a common endocrine disorder causing infertility among reproductiveage women. The molecular mechanisms underlying the development of PCOS are not well understood, and effective treatment options and therapeutic targets for PCOS are not available. This study was designed to investigate the role and therapeutic potential of miR-324 in PCOS.
Background
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder involving hyper-androgenism, insensitivity to insulin, and oligoovulation [1, 2] . It affects approximately 10% of reproductive-age women, generally causing infertility [3] . PCOS is reported to increase the risk of type 2 diabetes [4] . Further, studies have shown that although women with mild PCOS tend to have normal ovulation, the disorder becomes chronic if untreated [5] . PCOS is also associated with increased androgen activity and often interferes with the biosynthesis of estrogen and progesterone. It has been reported that increased activity of androgen occurs in PCOS [6] . Although insulin-sensitizers such as metformin are used for the management of PCOS, such drugs have adverse effects that impair quality of life [7] . Therefore, research has focused on identifying the molecular mechanisms underlying PCOS to find the therapeutic targets for the complete treatment of PCOS. MicroRNAs (miRs) have been shown to have many roles in humans and have been reported to regulate the expression of 30% of human genes [8] . Around 20 nucleotides in length, miRs bind to the mRNAs of a wide array of human genes to enforce their transcriptional repression [9] . Studies directed at deciphering the roles of miRs have indicated that miR expression is often dysregulated under disease conditions; therefore, is believed that they may be involved in the onset and development of diseases such as cancer and diabetes [10] . A recent study indicated that miR-324 is aberrantly expressed in ovaries with of people with PCOS [11] , but the exact role of miR-324 is yet to be established. The present study was therefore designed to examine the expression of miR-324 in normal and PCOS ovarian tissues and to assess the role of miR-324 in the KGN cell line obtained from PCOS ovaries. Our results show that the expression of miR-324 was significantly downregulated in the PCOS ovaries and in the KGN ovarian granulosa cell line. Nonetheless, ectopic expression of miR-324 in KGN cells significantly suppressed KGN cell proliferation via induction of apoptotic cell death. Moreover, in silico analysis and dual-luciferase assay showed it exerts its effects on ovarian granulosa cells in PCOS by targeting WNT2B. Hence, miR-324 may prove essential in the management of PCOS.
Material and Methods

Clinical samples and cell lines
After obtaining informed consent from all participants, PCOS and normal ovaries tissues were obtained from 15 [12] . The study was also approved by the Institutional Ethics committee under approval number 005/HU/37A/2018. cDNA synthesis, qRT-PCR, and transfections RNA was isolated from the tissues and cell lines using RNeasy kits, and cDNA was synthesized with an Omniscript RT (Qiagen, Inc.) kit from 2 µg of the RNA. The cycling conditions were as follows: 95°C for 20 s, followed by 40 cycles of 95°C for 15 s, and 58°C for 1 min. The expression was estimated by 2 -DDCt method and actin was used as an internal control [13, 14] . The transfection of KGN with different cell constructs was carried out using Lipofectamine 2000 reagent as per the manufacturer's guidelines.
MTT cell viability assay
For assessment of cell viability, KGN was transfected with appropriate constructs and incubated for 24 h at 37°C and then incubated with MTT (500 µg/mL) for 4 h. SDS (10%) was then added to dissolve the blue formazan formed. Finally, the optical density was assessed at 570 nm with a spectrophotometer (BD Biosciences, San Jose, CA, USA) and cell viability was determined as the percentage of the control.
AO/EB staining assay
The transfected KGN cells (0.6×10 6 ) were cultured in 6-well plates for 24 h at 37°C. We placed 25 μl of cell culture onto a glass slide and stained it with a 1-µL solution of AO/EB. The slides were covered with cover slips and examined under a fluorescence microscope.
Annexin V/PI staining assay
An ApoScan kit was used to determine the apoptotic KGN cell percentage. In brief, the transfected KGN cells (5×10 5 cells per well) were incubated at 37°C for 24 h, followed by staining with annexin V-FITC or PI. The percentage of apoptotic KGN cells at each concentration was then determined by flow cytometry.
Target identification and dual luciferase assay
The miR-324 target was identified by TargetScan version 7. activity was estimated using a luciferase reporter assay kit as per the guidelines of the supplier. Renilla luciferase activity was used to normalize the data.
Western blotting
The transfected KGN cells were harvested by centrifugation. The cells were then lysed in lysis buffer containing the protease inhibitor. About 45 µg of proteins from each sample were subjected to 10% separation, followed by transfer to a polyvinylidene difluoride (PVDF) membrane. Next, fat-free milk was used to block the membrane at room temperature for 1 h. Thereafter, the membranes were treated with primary antibodies (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at 4°C overnight. Subsequently, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Finally, the signal was detected using the Odyssey Infrared Imaging System. Actin was used as control for normalization.
Statistical analysis
The experiments were performed in triplicate and the values represent the mean results of experiments carried out in triplicate ±SD. One-way ANOVA followed by Tukey's test with GraphPad prism 7 software was employed for statistical analysis. p<0.05 was taken to indicative a statistically significant difference.
Results miR-324 is significantly downregulated in PCOS ovaries and KGN cells
The miR-324 expression was examined in normal and PCOS ovary tissues by qRT-PCR ( Figure 1A) . The results showed that miR-324 exhibited aberrant expression and was significantly downregulated (p<0.05) in all PCOS ovary tissues ( Figure 1 ). The expression of miR-324 was more than 2-fold lower in the PCOS tissues relative to the normal ovarian tissues. The miR-324 expression was also examined in KGN ovarian granulosa cells and normal SV40 ovarian cells. The results showed that the expression of miR-12b was about 9-fold lower in the KGN cells relative to the normal SV40 cells ( Figure 1B) .
Overexpression of miR-324 KGN Cells triggers apoptosis
Next, we assessed the role of miR-324 in PCOS by transfecting KGN cells with either the miR-324 mimics or NC (negative control). The overexpression of miR-324 in KGN cells was validated by RT-PCR, showing that transfection of the KGN cells with miR-324 mimics resulted in a 6.2-fold increase in the miR-324 expression relative to NC-transfected cells (Figure 2A) . Then, the proliferation rate of the NC-and miR-324 mimics-transfected KGN cells was determined by MTT assay, showing that the transfection of KGN cells with miR-324 mimics significantly decreased cell viability ( Figure 2B ). To understand the mechanism of action of miR-324, AO/EB staining was also performed to examine if miR-324 overexpression triggers apoptosis in the KGN cells. AO/EB staining revealed that miR-324 overexpression activated apoptotic cell death in the KGN cells transfected with miR-324 mimics ( Figure 2C ). Annexin V/PI staining showed that the percentage of apoptotic cells was 28% in miR-324 mimics-transfected KGN ( Figure 2D ). We also performed Western blot analysis of the NC-and miR-324-transfected KGN cells, showing that miR-324 overexpression in KGN cells caused upregulation of Bax and cleaved caspase-3 and decrease of Bcl-2 ( Figure 3) . These results clearly indicate that overexpression of miR-324 inhibits the proliferation of the KGN cells by induction of apoptosis. 
miR-324 targets WNT2B in KGN cells
TargetScan analysis of miR-324 was performed to identify the target of miR-324 in KGN ovarian granulosa cells, and WNT2B was identified as the potential target of miR-324 in KGN ovarian granulosa cells ( Figure 4A) . Therefore, the expression of WNT2B was evaluated in the NC-and miR-324-transfected KGN cells, which revealed that the expression of WNT2B was significantly upregulated in KGN ( Figure 4B ). Nonetheless, Western blot analysis showed that overexpression of miR-324 in KGN cells decreased the expression of WNT2B ( Figure 4C ). Dual-luciferase assay was also performed, which further validated WNT2B as the target of miR-324 ( Figure 4D ). 
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WNT2B partially recues the effects of miR-324 overexpression on KGN cell proliferation
To understand the effects of WNT2B silencing on the proliferation of ovarian granulosa KGN cells, the GN cells were transfected with NC or Si-WNT2B and the silencing of WNT2B expression was validated by qRT-PCR analysis, showing a 9-fold decrease in WNT2B expression in Si-WNT2B-transfected cells relative to the NC-transfected KGN cells ( Figure 5A ). MTT showed that Si-WNT2B silencing caused a significant (p<0.05) decrease in the viability of the KGN cells ( Figure 5B ). These effects were almost identical to that of miR-324 overexpression.
We also assessed the effects of WNT2B overexpression on the miR-324 mimics-transfected KGN cells, showing that WNT2B overexpression at least partially reversed the effects of miR-324 overexpression on the viability of KGN cells, which suggests that WNT2B is directly involved in the miR-324-mediated effects ( Figure 5C ).
Discussion
PCOS is a frequently diagnosed metabolic and endocrine abnormality and is one of the causes for infertility in woman [15] . Although researchers have sought to understand the molecular mechanisms underlying PCOS, the explicit cause of PCOS development is unclear. PCOS has been observed to be allied with changes in gonadotropin, enhancement of steroidogenic enzymes, insensitivity to insulin, and oligoovulation, as well as irregular menstruation, which in turn results in sub-fertility [16] . Dietary restriction and fasting have recently become popular to modify metabolism, even achieving durable epigenetic modulation. When fasting, the metabolic imbalance typical of PCOS may improve significantly [17] [18] [19] . Accumulating evidence suggests that one of the most important mechanisms in PCOS pathogenesis is insulin-resistance; therefore, the efficacy of insulin-sensitizers such as inositol isoforms has gained increasing attention [20, 21] . In addition, insulin-sensitizers like metformin are also utilized for the management of PCOS. However, these treatments are associated with a number of adverse effects. Moreover, PCOS has also been found to increase the risk of cancer development due to unrelenting 
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stimulation of endometrial tissue by estrogen [22] . It is imperative to explore treatment options for better management of PCOS. Over the last few decades, miRs have been considered to be important therapeutic targets for the management of deadly diseases [3] . Many miRs have been found to be dysregulated in PCOS ovaries. A previous study found that miR125b regulates the proliferation of ovarian granulosa cells in PCOS [22] , and another study reported that miR-483 is downregulated in polycystic ovarian syndrome and inhibits KGN cell proliferation [23] . Similarly, the expression of miR-324 has been shown to be dysregulated in PCOS ovaries [11] . Consistently, we observed that miR-324 is aberrantly downregulated in PCOS ovaries and in the ovarian granulosa KGN cell lines. Ectopic expression of miR-324 expression causes suppression of the proliferation of KGN cells by triggering apoptotic cell death of the KGN cells, which was also allied with increased expression of Bax and cleaved caspase 3. In addition, in silico analysis showed that miR-324 exerts its effects
